Viela Bio Overview

  • Founded
  • 2017
Founded
  • Status
  • Public
  • Employees
  • 166
Employees
  • Stock Symbol
  • VIE
Stock Symbol
  • Share Price
  • $33.94
  • (As of Thursday Closing)

Viela Bio General Information

Description

Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.

Contact Information

Website
www.vielabio.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • One MedImmune Way
  • First Floor, Area Two
  • Gaithersburg, MD 20878
  • United States

Viela Bio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Viela Bio Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$33.94 $35.46 $25.02 - $70.66 $1.86B 54.8M 198K -$2.46

Viela Bio Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,112,152 1,652,631
Revenue 32,316 50,000 0
EBITDA (132,073) (89,507) (192,294)
Net Income (128,849) (86,429) (190,270)
Total Assets 427,597 384,054 139,827
Total Debt 974 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Viela Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Viela Bio‘s full profile, request access.

Request a free trial

Viela Bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Viela Bio‘s full profile, request access.

Request a free trial

Viela Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatme
Drug Discovery
Gaithersburg, MD
166 As of 2020
00000
00000000 00000

0000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitat
0000 000000000
Cambridge, MA
000
00.00 0000-00-00
00000000000 000

0000000

sectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Viela Bio Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Venture Capital-Backed Cambridge, MA 000 00000000000 000
0000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
0000000 Venture Capital-Backed Diepenbeek, Belgium 0 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed San Mateo, CA 00 00000 0000000000 0 00000
00000 0000 0000000 Private Equity-Backed Irving, TX 0000 00000 0000000 0000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Viela Bio Executive Team (8)

Name Title Board Seat Contact Info
Zhengbin Yao Ph.D Chief Executive Officer & Chairman
Aaron Ren Ph.D Executive & Senior Vice President
Jorn Drappa Ph.D Chief Medical Officer & Executive
Jim Kastenmayer General Counsel, Legal & Secretary, Administration
Soraya Madani Ph.D Vice President & Head of Portfolio Management and Regulatory Affairs
You’re viewing 5 of 8 executive team members. Get the full list »

Viela Bio Board Members (14)

Name Representing Role Since
Andreas Wicki Ph.D Self Board Member 000 0000
Edward Hu Ph.D 6 Dimensions Capital Board Member 000 0000
Pascal Soriot Self Board Member 000 0000
Rachelle Jacques Self Board Member 000 0000
Sean Tong Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Viela Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Viela Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Viela Bio‘s full profile, request access.

Request a free trial